2026 Vol.44, N°2 - Table of contents
February - Myositis 2026
One year in review
CER19730
2026,44,2
Pg. 0167-0177
Free to view
Idiopathic inflammatory myopathies: one year in review 2025
M. Diomedi, F. Fattorini, S. Aliberti, L.M. Bianchessi, A. Castellucci, J. Schmidt, L. Cavagna, L. Carli, S. Barsotti
DOI: https://doi.org/10.55563/clinexprheumatol/2z01e0
M. Diomedi, F. Fattorini, S. Aliberti, L.M. Bianchessi, A. Castellucci, J. Schmidt, L. Cavagna, L. Carli, S. Barsotti
DOI: https://doi.org/10.55563/clinexprheumatol/2z01e0
Editorial
CER19373
2026,44,2
Pg. 0178-0185
Free to view
Shared governance of international myositis networks
T. Liewluck, L.G. Rider, K. Cheng, H. Chinoy, M.M. Dimachkie, E. Dourado, P.C. Gandiga, D.A. Isenberg, K. Ardalan, S. Keret, S. Kim, P. Korsten, I.E. Lundberg, P.M. Machado, F.W. Miller, C. Papadopoulou, S. Rosina, L.A. Saketkoo, S. Schlüter, J. Vencovský, A.J. Van Der Kooi, J. Schmidt
DOI: https://doi.org/10.55563/clinexprheumatol/dfli8l
T. Liewluck, L.G. Rider, K. Cheng, H. Chinoy, M.M. Dimachkie, E. Dourado, P.C. Gandiga, D.A. Isenberg, K. Ardalan, S. Keret, S. Kim, P. Korsten, I.E. Lundberg, P.M. Machado, F.W. Miller, C. Papadopoulou, S. Rosina, L.A. Saketkoo, S. Schlüter, J. Vencovský, A.J. Van Der Kooi, J. Schmidt
DOI: https://doi.org/10.55563/clinexprheumatol/dfli8l
Environmental Rheumatology
CER19007
2026,44,2
Pg. 0186-0193
Free to view
The MicroIBioM study: the gut microbiome in inclusion body myositis
M. Winkler, W. Seel, C. Kornblum, M.-C. Simon, J. Reimann
DOI: https://doi.org/10.55563/clinexprheumatol/1b8sv1
M. Winkler, W. Seel, C. Kornblum, M.-C. Simon, J. Reimann
DOI: https://doi.org/10.55563/clinexprheumatol/1b8sv1
CER19352
2026,44,2
Pg. 0194-0198
Free to view
Comparison of pre- and post-natal environmental exposures in United States versus Brazilian patients with juvenile dermatomyositis
T.M. Arabi, S.C. Farhat, C.C. Valoes, S. Shenoi, S. Kim, B.O. Carneiro, L.G. Rider, A.M. Elias
DOI: https://doi.org/10.55563/clinexprheumatol/d72tz5
T.M. Arabi, S.C. Farhat, C.C. Valoes, S. Shenoi, S. Kim, B.O. Carneiro, L.G. Rider, A.M. Elias
DOI: https://doi.org/10.55563/clinexprheumatol/d72tz5
Full Papers
CER18378
2026,44,2
Pg. 0199-0209
Free to view
Predictors of thrombotic events in patients with idiopathic inflammatory myopathies
S.S. Bae, J. Wang, A. Shahbazian, D. Markovic, Y. Lee, T. De Leon, D. Elashoff, C. Charles-Schoeman
DOI: https://doi.org/10.55563/clinexprheumatol/bj7nq2
S.S. Bae, J. Wang, A. Shahbazian, D. Markovic, Y. Lee, T. De Leon, D. Elashoff, C. Charles-Schoeman
DOI: https://doi.org/10.55563/clinexprheumatol/bj7nq2
CER18602
2026,44,2
Pg. 0210-0217
Free to view
Analysis of clinical features and risk factors for patients with idiopathic inflammatory myopathy complicated by Pneumocystis jirovecii pneumonia
J. Li, W. Huang, F. Ren, L. Luo, D. Chen, D. Huang, J. Zhou, L. Tang
DOI: https://doi.org/10.55563/clinexprheumatol/fpbkc8
J. Li, W. Huang, F. Ren, L. Luo, D. Chen, D. Huang, J. Zhou, L. Tang
DOI: https://doi.org/10.55563/clinexprheumatol/fpbkc8
CER18631
2026,44,2
Pg. 0218-0224
Free to view
Pneumocystis jirovecii pneumonia in anti-MDA5-positive dermatomyositis: characterisation, risk factors and prognosis
L. Yang, Q. Yang, J. Li, L. Zhang, S. Liu, C. Lian
DOI: https://doi.org/10.55563/clinexprheumatol/hpx173
L. Yang, Q. Yang, J. Li, L. Zhang, S. Liu, C. Lian
DOI: https://doi.org/10.55563/clinexprheumatol/hpx173
CER18610
2026,44,2
Pg. 0225-0233
Free to view
Cardiac involvement in patients with anti-melanoma differentiation-associated gene-5 antibody-positive dermatomyositis
Y. Wang, X. Chen, Z. Huang, Y. Wang, W. Jiang, J. Lei, S. Xie, L. Zhang
DOI: https://doi.org/10.55563/clinexprheumatol/r1f2g9
Y. Wang, X. Chen, Z. Huang, Y. Wang, W. Jiang, J. Lei, S. Xie, L. Zhang
DOI: https://doi.org/10.55563/clinexprheumatol/r1f2g9
CER18678
2026,44,2
Pg. 0234-0239
Free to view
Short Form 36 (SF-36) health survey questionnaire in health-related quality of life assessment in patients with inflammatory myopathies
A. Razok, J. Taylor, E. Ritz, K. Wipfler, K. Michaud, D. Saygin
DOI: https://doi.org/10.55563/clinexprheumatol/sbc4v3
A. Razok, J. Taylor, E. Ritz, K. Wipfler, K. Michaud, D. Saygin
DOI: https://doi.org/10.55563/clinexprheumatol/sbc4v3
CER18770
2026,44,2
Pg. 0240-0246
Free to view
Prevalence and early detection of myocarditis in idiopathic inflammatory myopathies: a prospective single-centre study
C.R. Calhoun, C.M. Connolly, J. Albayda, E. Tiniakou, C. Mecoli, B. Adler, L. Christopher-Stine, L. Adamo, S.L. Zimmerman, N.N. Gilotra, J. Paik
DOI: https://doi.org/10.55563/clinexprheumatol/2pndb8
C.R. Calhoun, C.M. Connolly, J. Albayda, E. Tiniakou, C. Mecoli, B. Adler, L. Christopher-Stine, L. Adamo, S.L. Zimmerman, N.N. Gilotra, J. Paik
DOI: https://doi.org/10.55563/clinexprheumatol/2pndb8
CER18745
2026,44,2
Pg. 0247-0254
Free to view
Clinical phenotypes and long-term outcomes of anti-SRP versus anti-HMGCR immune-mediated necrotising myopathy: a 13-year single-centre study
K.E. Clark, L.M. Clayton, R.G. Thomas, S.G. Kelly, L. Walker, A.S. Herrey, A. Dougan, R.S. Patel, S. Fhadil, T.O. Millner, S. Marino, A. Radunovic
DOI: https://doi.org/10.55563/clinexprheumatol/icqeff
K.E. Clark, L.M. Clayton, R.G. Thomas, S.G. Kelly, L. Walker, A.S. Herrey, A. Dougan, R.S. Patel, S. Fhadil, T.O. Millner, S. Marino, A. Radunovic
DOI: https://doi.org/10.55563/clinexprheumatol/icqeff
CER18890
2026,44,2
Pg. 0255-0267
Free to view
Peripheral blood immunophenotypic diversity in patients with anti-MDA5+ dermatomyositis and its impact on prognosis
Y. Zhang, R. Liu, W. Hu, T. Li, T. Li, W. Guan, L. Zhang, Y. He, C. Lian, J. Sun, S. Liu, P. Zhang
DOI: https://doi.org/10.55563/clinexprheumatol/qumg88
Y. Zhang, R. Liu, W. Hu, T. Li, T. Li, W. Guan, L. Zhang, Y. He, C. Lian, J. Sun, S. Liu, P. Zhang
DOI: https://doi.org/10.55563/clinexprheumatol/qumg88
CER18930
2026,44,2
Pg. 0268-0272
Free to view
Assessment of myositis specific antibodies in primary chronic arthritis: single centre prospective study
G. Zanframundo, L.M. Bianchessi, V. Codullo, F. Bottazzi, M. Guerini, L. De Stefano, F. Niedda, C. Alpini, R. Caporali, S. Bugatti, C. Montecucco, L. Cavagna
DOI: https://doi.org/10.55563/clinexprheumatol/z438d5
G. Zanframundo, L.M. Bianchessi, V. Codullo, F. Bottazzi, M. Guerini, L. De Stefano, F. Niedda, C. Alpini, R. Caporali, S. Bugatti, C. Montecucco, L. Cavagna
DOI: https://doi.org/10.55563/clinexprheumatol/z438d5
CER19075
2026,44,2
Pg. 0273-0278
Free to view
Alterations of mucosal-associated invariant T cells in dermatomyositis
S. Ye, J. Du, Y. Zhang, W. Wei, Y. Li
DOI: https://doi.org/10.55563/clinexprheumatol/vp3uim
S. Ye, J. Du, Y. Zhang, W. Wei, Y. Li
DOI: https://doi.org/10.55563/clinexprheumatol/vp3uim
CER19063
2026,44,2
Pg. 0279-0288
Free to view
Health-related quality of life improvements and response thresholds of myositis outcome measures and response criteria
M. Almackenzie, A. Aggarwal, S. Keret, T. Chandra, R. Lomanto Silva, E. Gkiaouraki, N. Pongtarakulpanit, S. Moghadam-Kia, C.V. Oddis, R. Aggarwal
DOI: https://doi.org/10.55563/clinexprheumatol/zcooap
M. Almackenzie, A. Aggarwal, S. Keret, T. Chandra, R. Lomanto Silva, E. Gkiaouraki, N. Pongtarakulpanit, S. Moghadam-Kia, C.V. Oddis, R. Aggarwal
DOI: https://doi.org/10.55563/clinexprheumatol/zcooap
CER19019
2026,44,2
Pg. 0289-0296
Free to view
The Refractory DermatoMyositis Index (ReDMI): a clinical tool to predict refractory disease in patients with dermatomyositis
Y. Reyna-Juárez, N.R. Mejía-Domínguez, M.J. Ostos-Prado, B. Alcalá-Carmona, J.T. Balderas-Miranda, A. Gaytán, A. Hernández-López, C.A. Núñez-Álvarez, M.E. Baños-Laredo, M.L. Domínguez-López, K. Santana De Anda, D. Gómez-Martín, J. Torres-Ruiz
DOI: https://doi.org/10.55563/clinexprheumatol/k77xaj
Y. Reyna-Juárez, N.R. Mejía-Domínguez, M.J. Ostos-Prado, B. Alcalá-Carmona, J.T. Balderas-Miranda, A. Gaytán, A. Hernández-López, C.A. Núñez-Álvarez, M.E. Baños-Laredo, M.L. Domínguez-López, K. Santana De Anda, D. Gómez-Martín, J. Torres-Ruiz
DOI: https://doi.org/10.55563/clinexprheumatol/k77xaj
CER19164
2026,44,2
Pg. 0297-0303
Free to view
Janus kinase inhibitors therapy in idiopathic inflammatory myopathies: a case series
A.L. Vasconcelos, A. Marinho, A. Campar
DOI: https://doi.org/10.55563/clinexprheumatol/0yu9gm
A.L. Vasconcelos, A. Marinho, A. Campar
DOI: https://doi.org/10.55563/clinexprheumatol/0yu9gm
CER19211
2026,44,2
Pg. 0304-0312
Free to view
Potential pitfalls in the differential diagnosis of myositis versus hereditary myopathies
S. Glaubitz, R. Zeng, K. Hasanov, S. Pauli, J. Schmidt
DOI: https://doi.org/10.55563/clinexprheumatol/pqmby3
S. Glaubitz, R. Zeng, K. Hasanov, S. Pauli, J. Schmidt
DOI: https://doi.org/10.55563/clinexprheumatol/pqmby3
CER19077
2026,44,2
Pg. 0313-0319
Free to view
Factors associated with endomysial fibrosis in anti-signal recognition particle antibody immune-mediated necrotising myopathy
J. Yuan, M. Yang, Y. Zheng, H. Hao, F. Gao, W. Zhang, Z. Wang, Y. Yuan, Y. Zhao
DOI: https://doi.org/10.55563/clinexprheumatol/bzpse1
J. Yuan, M. Yang, Y. Zheng, H. Hao, F. Gao, W. Zhang, Z. Wang, Y. Yuan, Y. Zhao
DOI: https://doi.org/10.55563/clinexprheumatol/bzpse1
CER19348
2026,44,2
Pg. 0320-0329
Free to view
Cardiac involvement in newly diagnosed patients with idiopathic inflammatory myopathies is associated with skeletal muscle involvement
B. Hanna, C.L. Polte, E. Sakiniene, J. Von Brömsen, E. Bollano, I.E. Lundberg, R. Pullerits, T. Jin
DOI: https://doi.org/10.55563/clinexprheumatol/h01mjl
B. Hanna, C.L. Polte, E. Sakiniene, J. Von Brömsen, E. Bollano, I.E. Lundberg, R. Pullerits, T. Jin
DOI: https://doi.org/10.55563/clinexprheumatol/h01mjl
CER19017
2026,44,2
Pg. 0330-0338
Free to view
Validation of simplified scoring systems for assessing cutaneous disease activity in dermatomyositis
N. Pongtarakulpanit, A. Bishnoi, T. Chandra, S. Dzanko, E. Gkiaouraki, S. Keret, R. Lomanto Silva, S. Sriram, D. Saygin, V.M. Liarski, D.P. Ascherman, S. Moghadam-Kia, C.V. Oddis, R. Aggarwal
DOI: https://doi.org/10.55563/clinexprheumatol/8lq4aq
N. Pongtarakulpanit, A. Bishnoi, T. Chandra, S. Dzanko, E. Gkiaouraki, S. Keret, R. Lomanto Silva, S. Sriram, D. Saygin, V.M. Liarski, D.P. Ascherman, S. Moghadam-Kia, C.V. Oddis, R. Aggarwal
DOI: https://doi.org/10.55563/clinexprheumatol/8lq4aq
CER19282
2026,44,2
Pg. 0339-0344
Free to view
Recurrent and new primary cancer risk in adult patients with idiopathic inflammatory myositis and a history of malignancy
X. Wang, J. Albayda, J.J. Paik, E. Tiniakou, B.L. Adler, A.L. Mammen, L. Casciola-Rosen, L. Christopher-Stine, C.A. Mecoli
DOI: https://doi.org/10.55563/clinexprheumatol/dlho6a
X. Wang, J. Albayda, J.J. Paik, E. Tiniakou, B.L. Adler, A.L. Mammen, L. Casciola-Rosen, L. Christopher-Stine, C.A. Mecoli
DOI: https://doi.org/10.55563/clinexprheumatol/dlho6a
CER19099
2026,44,2
Pg. 0345-0352
Free to view
Fitbit as an activity monitor in idiopathic inflammatory myopathy: results from a real-world cohort
A. Sharma, S. Keret, B. Rockette-Wagner, R. Lomanto Silva, T. Chandra, S. Moghadam-Kia, C.V. Oddis, R. Aggarwal
DOI: https://doi.org/10.55563/clinexprheumatol/rihi7r
A. Sharma, S. Keret, B. Rockette-Wagner, R. Lomanto Silva, T. Chandra, S. Moghadam-Kia, C.V. Oddis, R. Aggarwal
DOI: https://doi.org/10.55563/clinexprheumatol/rihi7r
Reviews
CER18696
2026,44,2
Pg. 0353-0367
Free to view
Non-inflammatory mimickers of myositis: a guide for rheumatologists
S.P. Silva, M. Pinto, D. Costa, A. Azevedo, E. Dourado
DOI: https://doi.org/10.55563/clinexprheumatol/v0joqy
S.P. Silva, M. Pinto, D. Costa, A. Azevedo, E. Dourado
DOI: https://doi.org/10.55563/clinexprheumatol/v0joqy
CER19374
2026,44,2
Pg. 0368-0375
Free to view
Shaping the landscape of interstitial lung disease in idiopathic inflammatory myopathies: state of the art, evidence gaps and a need for clinical trials
D. Rivero Gallegos, F.M. Pais, T. Lan, C. Papadopoulou, E.K. Joerns, J. Paul, J. Rojas Serrano, T. Kulkarni, P.C. Gandiga, H. So, K. Houghton, N. Bagri, M. Jansen, B. Bader Meunier, E.M. Wilfong, R. Aggarwal, R.W. Hallowell, V. Nagaraja
DOI: https://doi.org/10.55563/clinexprheumatol/rsnsu2
D. Rivero Gallegos, F.M. Pais, T. Lan, C. Papadopoulou, E.K. Joerns, J. Paul, J. Rojas Serrano, T. Kulkarni, P.C. Gandiga, H. So, K. Houghton, N. Bagri, M. Jansen, B. Bader Meunier, E.M. Wilfong, R. Aggarwal, R.W. Hallowell, V. Nagaraja
DOI: https://doi.org/10.55563/clinexprheumatol/rsnsu2
CER19372
2026,44,2
Pg. 0376-0383
Free to view
Pain in myositis: prevalence, assessment, potential mechanisms and considerations for management
S. Glaubitz, Y.C. Lee, D. Saygin
DOI: https://doi.org/10.55563/clinexprheumatol/4msi8i
S. Glaubitz, Y.C. Lee, D. Saygin
DOI: https://doi.org/10.55563/clinexprheumatol/4msi8i
CER19732
2026,44,2
Pg. 0384-0389
Free to view
Mitochondrial abnormalities in idiopathic inflammatory myopathies
F. Torri, G. Ricci, M. Mancuso, G. Siciliano
DOI: https://doi.org/10.55563/clinexprheumatol/qctyi2
F. Torri, G. Ricci, M. Mancuso, G. Siciliano
DOI: https://doi.org/10.55563/clinexprheumatol/qctyi2
Paediatric Rheumatology
CER18292
2026,44,2
Pg. 0390-0397
Free to view
Treatment outcomes in 63 cases of juvenile dermatomyositis-associated calcinosis
B.Y. Yi, D.M. Wahezi, L. Covert, K. Ardalan, J. Hui-Yuen, N. Vasquez-Canizares, D.M. Mosa, M. Jones, C. Correll, A. Begezda, S. Shenoi, E.Y. Wu, L.K. Kovalick, W.B. Lapin, S.E. Tarvin, M.S. Oliver, M.M. Rodriguez, I. Marmor, K.W. Baszis, A.J. Taxter, A.C. Hanson, C.S. Crowson, A.B. Orandi
for the CARRA Juvenile Dermatomyositis, Calcinosis Subcommittee
DOI: https://doi.org/10.55563/clinexprheumatol/35pbbq
B.Y. Yi, D.M. Wahezi, L. Covert, K. Ardalan, J. Hui-Yuen, N. Vasquez-Canizares, D.M. Mosa, M. Jones, C. Correll, A. Begezda, S. Shenoi, E.Y. Wu, L.K. Kovalick, W.B. Lapin, S.E. Tarvin, M.S. Oliver, M.M. Rodriguez, I. Marmor, K.W. Baszis, A.J. Taxter, A.C. Hanson, C.S. Crowson, A.B. Orandi
for the CARRA Juvenile Dermatomyositis, Calcinosis Subcommittee
DOI: https://doi.org/10.55563/clinexprheumatol/35pbbq
CER18814
2026,44,2
Pg. 0398-0407
Free to view
Association of NXP2 autoantibodies with a more severe clinical phenotype of juvenile dermatomyositis
Y. Wang, J. Liang, J. Wang, F. Zheng, L. Teng, Q. Ma, Y. Zhou, L. Liang, J. Lin, M. Lu, H. Cao, X. Xu
DOI: https://doi.org/10.55563/clinexprheumatol/820f4x
Y. Wang, J. Liang, J. Wang, F. Zheng, L. Teng, Q. Ma, Y. Zhou, L. Liang, J. Lin, M. Lu, H. Cao, X. Xu
DOI: https://doi.org/10.55563/clinexprheumatol/820f4x
Letters to the Editor
CER18791
2026,44,2
Pg. 0408-0409
Free to view
Successful therapy of refractory dermatomyositis skin rash with anifrolumab
C. Galluzzo, N. Pipitone, I. Chiapparoli, C. Salvarani
DOI: https://doi.org/10.55563/clinexprheumatol/haftre
C. Galluzzo, N. Pipitone, I. Chiapparoli, C. Salvarani
DOI: https://doi.org/10.55563/clinexprheumatol/haftre
CER18732
2026,44,2
Pg. 0410-0411
Free to view
Statins and ribociclib interaction induced necrotising myopathy: a case report and literature review
F. Torri, G. Vadi, G. Aringhieri, G. Alì, F. Siciliano, G. Ricci, G. Siciliano
DOI: https://doi.org/10.55563/clinexprheumatol/6a80k4
F. Torri, G. Vadi, G. Aringhieri, G. Alì, F. Siciliano, G. Ricci, G. Siciliano
DOI: https://doi.org/10.55563/clinexprheumatol/6a80k4
CER18967
2026,44,2
Pg. 0412
Free to view
Comment on: Triple-combination therapy did not improve prognosis in anti-MDA5 positive dermatomyositis: a multicentre longitudinal cohort study by You et al.
W. Rojas-Zuleta
DOI: https://doi.org/10.55563/clinexprheumatol/spyyh8
W. Rojas-Zuleta
DOI: https://doi.org/10.55563/clinexprheumatol/spyyh8
CER19067
2026,44,2
Pg. 0413
Free to view
Comment on: Successful management of pulmonary hypertension with baricitinib in a dermatomyositis patient
C. Pinto Oliveira, M.D. Pascoal, A.R. Prata, D. Carvalho, M.G. Castro, E. Dourado
DOI: https://doi.org/10.55563/clinexprheumatol/jk5vx1
C. Pinto Oliveira, M.D. Pascoal, A.R. Prata, D. Carvalho, M.G. Castro, E. Dourado
DOI: https://doi.org/10.55563/clinexprheumatol/jk5vx1
CER19227
2026,44,2
Pg. 0414
Free to view
Reply to the comment on: Successful management of pulmonary hypertension with baricitinib in a dermatomyositis patient
C. Rizzo, L. La Barbera, G. Guggino
DOI: https://doi.org/10.55563/clinexprheumatol/g129j4
C. Rizzo, L. La Barbera, G. Guggino
DOI: https://doi.org/10.55563/clinexprheumatol/g129j4
CER19104
2026,44,2
Pg. 0415-0416
Free to view
Efficacy of rituximab treatment in a post-COVID-19 vaccine myositis overlapping to systemic sclerosis: a histological follow-up
F. Bandinelli, G. Dallagiacoma, F. Nozzoli, M. Capassoni, R. Nassini
DOI: https://doi.org/10.55563/clinexprheumatol/8xtlep
F. Bandinelli, G. Dallagiacoma, F. Nozzoli, M. Capassoni, R. Nassini
DOI: https://doi.org/10.55563/clinexprheumatol/8xtlep
CER19061
2026,44,2
Pg. 0417-0418
Free to view
Neutrophil-to-lymphocyte ratio as a prognostic indicator in anti-MDA5 dermatomyositis with interstitial lung disease and its link to IFN-α and IL-6
Y. Endo, T. Koga, Y. Mizunoo, T. Shimizu, N. Sakamoto, A. Kawakami
DOI: https://doi.org/10.55563/clinexprheumatol/4tfy7u
Y. Endo, T. Koga, Y. Mizunoo, T. Shimizu, N. Sakamoto, A. Kawakami
DOI: https://doi.org/10.55563/clinexprheumatol/4tfy7u
CER19379
2026,44,2
Pg. 0419
Free to view
Comment on: Cancer-associated myositis before and after the COVID-19 pandemic onset
F.M. Costa, R. Campanilho-Marques, E. Dourado, M. Bandeira, B. Correia, A.T. Melo, F. Saraiva, S.C. Barreira, J.E. Fonseca
DOI: https://doi.org/10.55563/clinexprheumatol/uvfg30
F.M. Costa, R. Campanilho-Marques, E. Dourado, M. Bandeira, B. Correia, A.T. Melo, F. Saraiva, S.C. Barreira, J.E. Fonseca
DOI: https://doi.org/10.55563/clinexprheumatol/uvfg30
CER19390
2026,44,2
Pg. 0420
Free to view
Reply to the comment on: Cancer-associated myositis before and after the COVID-19 pandemic onset
H. Daungsupawong, V. Wiwanitkit
DOI: https://doi.org/10.55563/clinexprheumatol/sd3zxa
H. Daungsupawong, V. Wiwanitkit
DOI: https://doi.org/10.55563/clinexprheumatol/sd3zxa
CER18908
2026,44,2
Pg. 0421-0422
Free to view
Dermatomyositis assessment of rash via telemedicine: a preliminary study
N. Pongtarakulpanit, A. Bishnoi, D.P. Ascherman, S. Moghadam-Kia, C.V. Oddis, R. Aggarwal
DOI: https://doi.org/10.55563/clinexprheumatol/g16i0y
N. Pongtarakulpanit, A. Bishnoi, D.P. Ascherman, S. Moghadam-Kia, C.V. Oddis, R. Aggarwal
DOI: https://doi.org/10.55563/clinexprheumatol/g16i0y
CER19329
2026,44,2
Pg. 0423-0424
Free to view
Complete clinical and serological remission of anti-synthetase syndrome after autologous haematopoietic stem cell transplantation
V. Ruiz-Esquide, S. Prieto-Gonzalez, E. Ruiz-Ortiz, C. Arnaldos
DOI: https://doi.org/10.55563/clinexprheumatol/vezebx
V. Ruiz-Esquide, S. Prieto-Gonzalez, E. Ruiz-Ortiz, C. Arnaldos
DOI: https://doi.org/10.55563/clinexprheumatol/vezebx
CER19532
2026,44,2
Pg. 0425-0426
Free to view
Acquired generalised lipodystrophy as an uncommon complication of anti-Mi-2 dermatomyositis: a case report
A. Bustos-Merlo, M. Martín-Armada, M. Zamora-Pasadas, I. Sánchez-Berná, N. Navarrete-Navarrete
DOI: https://doi.org/10.55563/clinexprheumatol/0mkobh
A. Bustos-Merlo, M. Martín-Armada, M. Zamora-Pasadas, I. Sánchez-Berná, N. Navarrete-Navarrete
DOI: https://doi.org/10.55563/clinexprheumatol/0mkobh